 radiotherapi outlook patient year pediatr oncolog group stage neuroblastoma children year age complet partial remov primari tumor posit intracavitari lymph node pediatr oncolog group pog stage small higher-risk subset patient import patient pog stage neuroblastoma efficaci toxic concurr radiat therapi RT CT children random studi elig patient cyclophosphamid day adriamycin doxorubicin adria columbu OH IV day cyc/adr week cours RT tumor region lymph node fraction second-look surgeri respons residu diseas continu therapi cyc/adr week cisplatin day teniposid day cdp/vm cours secondari CT cdp/vm avail patient complet respons CR induct treatment second-look surgeri elig patient CT CR disease-fre ned month median month therapi twenty-two elig case ct/rt CR ned month median month therapi local metastat relaps arm differ CR event-fre surviv surviv rate signific surgic complianc excel complic uncommon therapi toler group hematopoiet toxic common ct/rt arm pog stage neuroblastoma children year age higher-risk group ct/rt superior initi long-term diseas control CT patient subset occurr metastat failur treatment group need aggress chemotherapi